If you have spent any time sourcing research compounds, you will have noticed that purity percentages vary significantly between suppliers. A peptide listed at 95% purity and one listed at 99% purity may look similar on a product page. In practice, that difference can be the deciding factor between reliable data and a failed experiment.
In this post, we explore what purity actually means in the context of research peptides, how it is measured, and why DNA Gold has made third-party verification a non-negotiable part of our supply process.
When a peptide is described as having 98% purity, it means that 98% of the material in the vial is the intended compound. The remaining 2% consists of impurities — which may include incomplete synthesis fragments, reagent residues, counter-ions, water content, or uncharacterised by-products.
The challenge is that impurities are not always inert. Some can actively interfere with biological assays. Others may bind to the same receptors as the intended compound, generating misleading results. Even trace contamination from solvents used in the synthesis process can affect cell viability in in vitro models.
” Purity is not just a number on a document. It is the difference between research you can trust and research you cannot. “
The gold standard for peptide purity analysis is High-Performance Liquid Chromatography, commonly known as HPLC. This technique separates compounds by their chemical properties as they pass through a column under high pressure, producing a chromatogram that identifies the proportion of the target compound versus all other species present in the sample.
Alongside HPLC, reputable suppliers also use:
At DNA Gold, every product in our catalogue is tested using HPLC with mass spectrometry confirmation. Results are documented in a batch-specific Certificate of Analysis that is available for each product.
📷 SUGGESTED IMAGE: HPLC chromatogram graph / laboratory analytical equipment — search: ‘HPLC chromatogram peptide analysis laboratory’
One of the most common issues in the research compound supply chain is the reliance on self-reported or manufacturer-supplied purity data. A supplier may list a compound as 98% pure based on testing carried out by the same facility that produced it — with no independent verification.
This creates an obvious conflict of interest. The financial incentive to report high purity can, in some cases, outweigh the scientific rigour required to actually achieve it.
This is precisely why DNA Gold conducts additional independent third-party testing. We do not simply pass on the supplier’s certificate. We verify it. If a compound fails to meet our internal purity benchmarks, it does not reach our catalogue.
The appropriate purity level depends on the type of research being conducted:
When in doubt, higher purity is always preferable. The incremental cost of a higher-purity compound is negligible compared to the cost of unreliable data, repeated experiments, or a compromised publication.
Every DNA Gold shipment includes a Certificate of Analysis (CoA) that details:
We encourage researchers to file CoAs alongside their experimental records. Proper documentation not only supports good laboratory practice — it is essential if your research is heading toward publication or regulatory review
